JIANG Yongling, HU Yu. Comparison of efficacy of Chinese-Thyroid Imaging Reporting and Data System and American Thyroid Association ultrasound model in diagnosis of thyroid nodule[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 6-9. DOI: 10.7619/jcmp.20214598
Citation: JIANG Yongling, HU Yu. Comparison of efficacy of Chinese-Thyroid Imaging Reporting and Data System and American Thyroid Association ultrasound model in diagnosis of thyroid nodule[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 6-9. DOI: 10.7619/jcmp.20214598

Comparison of efficacy of Chinese-Thyroid Imaging Reporting and Data System and American Thyroid Association ultrasound model in diagnosis of thyroid nodule

More Information
  • Received Date: November 22, 2021
  • Available Online: March 28, 2022
  • Published Date: March 14, 2022
  •   Objective  To compare the diagnostic value of Chinese-Thyroid Imaging Reporting and Data System (C-TIRADS) and American Thyroid Association (ATA) ultrasonic model in benign and malignant thyroid nodules.
      Methods  The ultrasound images of 245 patients with thyroid nodules confirmed by pathological results were analyzed retrospectively. C-TIRADS and ATA ultrasound models were used for thyroid nodules classification, respectively. The diagnostic efficacy of the two diagnostic models was compared.
      Results  The areas under the receiver operating characteristic (ROC) curves of C-TIRADS and ATA ultrasound models were 0.750 and 0.625, respectively. The sensitivity and specificity of C-TIRADS in diagnosis of benign and malignant thyroid nodules were 97.7% and 52.2%, respectively. The sensitivity and specificity of ATA ultrasound model in diagnosis of benign and malignant thyroid nodules were 99.2% and 25.7%, respectively.
      Conclusion  C-TIRADS has higher diagnostic efficacy and specificity than ATA model in diagnosis of benign and malignant thyroid nodules, which can reduce the misdiagnosis rate of benign thyroid nodules of patients.
  • [1]
    VACCARELLA S, FRANCESCHI S, BRAY F, et al. Worldwide thyroid-cancer epidemic The increasing impact of overdiagnosis[J]. N Engl J Med, 2016, 375(7): 614-617. doi: 10.1056/NEJMp1604412
    [2]
    GHARIB H, PAPINI E, GARBER J R, et al. American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: 2016 update[J]. Endocr Pract, 2016, 22(5): 622-639.
    [3]
    ZHOU J Q, YIN L X, WEI X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS[J]. Endocrine, 2020, 70(2): 256-279. doi: 10.1007/s12020-020-02441-y
    [4]
    HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
    [5]
    中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版)[J]. 中华普通外科学文献: 电子版, 2019, 13(1): 1-15. doi: 10.3877/cma.j.issn.1674-0793.2019.01.001
    [6]
    尹海霞, 岳芮杰. 老年甲状腺良性结节可疑超声特征与病理对照分析[J]. 中国老年学杂志, 2016, 36(12): 3012-3013. doi: 10.3969/j.issn.1005-9202.2016.12.090
    [7]
    汪珺莉, 马千清, 强邦红, 等. ACR TI-RADS与ATA超声模型对甲状腺良恶性结节诊断价值的比较[J]. 皖南医学院学报, 2020, 39(4): 376-379. doi: 10.3969/j.issn.1002-0217.2020.04.020
    [8]
    GAO L Y, XI X H, JIANG Y X, et al. Comparison among TIRADS (ACR TI-RADS and KWAK-TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules[J]. Endocrine, 2019, 64(1): 90-96. doi: 10.1007/s12020-019-01843-x
    [9]
    周建桥, 詹维伟. 2020年中国超声甲状腺影像报告和数据系统(C-TIRADS)指南解读[J]. 诊断学理论与实践, 2020, 19(4): 350-353. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS202004008.htm
    [10]
    HUANG B L, EBNER S A, MAKKAR J S, et al. A multidisciplinary head-to-head comparison of American college of radiology thyroid imaging and reporting data system and American thyroid association ultrasound risk stratification systems[J]. Oncol, 2020, 25(5): 398-403. doi: 10.1634/theoncologist.2019-0362
    [11]
    徐婷, 顾经宇, 叶新华, 等. TIRADS与2015年美国甲状腺学会指南超声模式对甲状腺结节良恶性鉴别诊断效能的对比研究[J]. 中华内分泌代谢杂志, 2016, 32(12): 999-1002. doi: 10.3760/cma.j.issn.1000-6699.2016.12.005
    [12]
    郭丽娟, 周文艳, 孔岩, 等. 超声成像对甲状腺癌与甲状腺腺瘤的鉴别诊断价值[J]. 癌症进展, 2018, 16(14): 1724-1726. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201814009.htm
    [13]
    黄莉, 赵艳娜, 顾建华, 等. 超声检查在甲状腺囊实性结节随访中的应用价值[J]. 中华医学超声杂志: 电子版, 2020, 17(12): 1189-1192. doi: 10.3877/cma.j.issn.1672-6448.2020.12.008
    [14]
    黄媛婧, 李竹瑶, 贾勐, 等. 甲状腺髓样癌的超声特征分析[J]. 中华内分泌外科杂志, 2021, 15(1): 27-30. https://www.cnki.com.cn/Article/CJFDTOTAL-WYSB202105019.htm
  • Cited by

    Periodical cited type(4)

    1. 李丽芳,杨中男,刘力源,关郑军,徐艳,贺红丽,李燕萍. LncRNA LIPCAR在慢性心力衰竭患者外周血中的表达及临床意义. 宁夏医学杂志. 2024(09): 758-761 .
    2. 朱占占,孙雯雯,张申伟. 二甲双胍联合达格列净治疗2型糖尿病合并射血分数中间值心力衰竭患者的效果. 河南医学研究. 2022(21): 3980-3983 .
    3. 柳湘洁,刘晓霞. 沙库巴曲缬沙坦对射血分数中间值心力衰竭患者心功能及近期预后的影响. 临床和实验医学杂志. 2021(16): 1689-1692 .
    4. 左路广,黄冠杰,詹明华,李宝亮,张斌. 慢性心力衰竭并发感染患者病原学及脑钠肽变化研究. 实用临床医药杂志. 2021(19): 49-52 . 本站查看

    Other cited types(1)

Catalog

    Article views (290) PDF downloads (23) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return